We have to weave biology & technology into the DNA of U.S. national security.
We've been preparing tools and resources to support the medical community as well as decision makers, technologists, and other stakeholders to help understand, manage, and respond to COVID-19.
B.Next illuminates the national security implications of infectious disease outbreaks through thought leadership, proof-of-concept experimentation, and informing IQT investment strategy. We are building a trusted network linking government, academia, civil society, and private sector innovators.
Articles Feed - Homepage
B.Next COVID-19 Test Database
This database is a tool for those who need to quickly obtain information about COVID-19 test kits and services for use in the United States. The database includes molecular tests that have received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA), whether they are kits that can be purchased by lab managers, or tests performed as a service by laboratories, whether sourced from manufacturers, or developed for their own use (so called “laboratory-developed tests”, or LDTs).
COVID-19 Case Investigation and Contact Tracing: Considerations for Using Digital Technologies
Co-published by B.Next and the Association of State and Territorial Health Officials (ASTHO), this guide aims to help health officials think through critical functionalities needed for case investigations and contact tracing, technological options, and issues of implementation in adopting these technologies. It also addresses the latest topic of focus: the Apple/Google exposure notification application programming interface. The background and key considerations included are intended to inform decision-making for technology-enabled enhancement of case investigation and contact tracing capacity.
What We're Reading
Academic, private, and government institutions all produce meaningful research on an ongoing basis. Here are a few articles, books, and websites that capture some important perspectives on biodefense.